hi all
below is a summary listing of medical article citations
which contain references to Parkinson's disease and which
have been added to the PubMed WWWeb site in the past 30 days at:
<http://www.ncbi.nlm.nih.gov/PubMed/>
entering the PMID number in the search window there
will take you to an abstract [synopsis] of the article
[if one is available on-line]
in any case,
the full articles are accessible directly from the relevant medical journal
maybe on the web [at a cost] or at a good library [at no cost]
or maybe even at your own neurologist's office!
EDUCATION + TITRATION R US
janet
------------------------------------------------------------------------
Bezard E, et al.
Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor
disabilities in MPTP-treated monkey.
Prog Neuropsychopharmacol Biol Psychiatry. 1999 Oct;23(7):1237-46.
PMID: 10581645; UI: 20048346.
Stack E, et al.
Fall events described by people with Parkinson's disease: implications
for clinical interviewing and the research agenda.
Physiother Res Int. 1999;4(3):190-200.
PMID: 10581625; UI: 20048326.
Taylor CA, et al.
Environmental, medical, and family history risk factors for
Parkinson's disease: A New England-based case control study.
Am J Med Genet. 1999 Dec 15;88(6):742-749.
PMID: 10581500.
Schraen-Maschke S, et al.
Analysis of ERDA1, CTG18.1, and uncloned CAG/CTG repeat sequences in
familial Parkinson's disease with anticipation.
Am J Med Genet. 1999 Dec 15;88(6):738-741.
PMID: 10581499.
Kuhn DM, et al.
L-DOPA-quinone inactivates tryptophan hydroxylase and converts the
enzyme to a redox-cycling quinoprotein.
Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):78-84.
PMID: 10581400.
Schmidt J, et al.
Regulation of heme oxygenase-1 expression by dopamine in cultured C6
glioma and primary astrocytes.
Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):50-59.
PMID: 10581397.
Gerschlager W, et al.
Bilateral subthalamic nucleus stimulation improves frontal cortex
function in Parkinson's disease: An electrophysiological study of the
contingent negative variation.
Brain. 1999 Dec;122(12):2365-2373.
PMID: 10581229.
York MK, et al.
Neuropsychological outcome following unilateral pallidotomy.
Brain. 1999 Dec;122(12):2209-2220.
PMID: 10581217.
Liberatore GT, et al.
Inducible nitric oxide synthase stimulates dopaminergic
neurodegeneration in the MPTP model of Parkinson disease.
Nat Med. 1999 Dec;5(12):1403-1409.
PMID: 10581083.
Grunewald T, et al.
NOS knockouts and neuroprotection.
Nat Med. 1999 Dec;5(12):1354-1355.
PMID: 10581072.
Linda H, et al.
Expression of MHC class I heavy chain and beta2-microglobulin in rat
brainstem motoneurons and nigral dopaminergic neurons.
J Neuroimmunol. 1999 Nov 1;101(1):76-86.
PMID: 10580816; UI: 20046783.
Mizruchin A, et al.
Comparison of the effects of dopaminergic and serotonergic activity in
the CNS on the activity of the immune system.
J Neuroimmunol. 1999 Nov 15;101(2):201-4.
PMID: 10580803; UI: 20046770.
Aguirre JA, et al.
A stereological study on the neuroprotective actions of acute
modafinil treatment on MPTP induced nigral lesions of
the male black mouse.
Neurosci Lett. 1999 Nov 19;275(3):215-8.
PMID: 10580713; UI: 20046680.
Kodama Y, et al.
Auditory brainstem responses in patients with autonomic failure with
Parkinson's disease and multiple system atrophy.
J Auton Nerv Syst. 1999 Sep 24;77(2-3):184-9.
PMID: 10580301; UI: 20046246.
Huebscher KJ, et al.
Protein isoaspartyl methyltransferase protects from Bax-induced
apoptosis.
Gene. 1999 Nov 29;240(2):333-341.
PMID: 10580153.
Cenci MA, et al.
Changes in the regional and compartmental distribution of FosB- and
JunB-like immunoreactivity induced in the dopamine-denervated rat
striatum by acute or chronic L-dopa treatment.
Neuroscience. 1999;94(2):515-27.
PMID: 10579213; UI: 20043814.
Tarazi F, et al.
Dopamine D4 receptors: significance for molecular psychiatry at the
millennium.
Mol Psychiatry. 1999 Nov;4(6):529-538.
PMID: 10578234.
Schulze J, et al.
Clindamycin and nicotinic neuromuscular transmission.
Lancet. 1999 Nov 20;354(9192):1792-3.
PMID: 10577648; UI: 20043580.
Kraft E, et al.
Visual hallucinations, white matter lesions and disease severity in
Parkinson's disease.
Acta Neurol Scand. 1999 Jun;99(6):362-7.
PMID: 10577270; UI: 99314579.
Helmuth L.
Fetal cells help Parkinson's patients.
Science. 1999 Oct 29;286(5441):886-7. No abstract available.
PMID: 10577234; UI: 20041510.
Baggott M, et al.
More about parkinsonism after taking ecstasy.
N Engl J Med. 1999 Oct 28;341(18):1400-1. No abstract available.
PMID: 10577097; UI: 99450931.
Mazzoni P, et al.
The freezing of time as a presenting symptom of Parkinson's disease.
N Engl J Med. 1999 Oct 21;341(17):1317-8. No abstract available.
PMID: 10577086; UI: 99442293.
Bhatia KP, et al.
Botulinum toxin is a useful treatment in excessive drooling in saliva.
J Neurol Neurosurg Psychiatry. 1999 Nov;67(5):697. No abstract
available.
PMID: 10577041; UI: 20035692.
Seibyl JP.
Single-photon emission computed tomography of the dopamine transporter
in parkinsonism.
J Neuroimaging. 1999 Oct;9(4):223-8.
PMID: 10540602; UI: 20008107.
Zakzanis KK, et al.
A neuropsychological comparison of demented and nondemented patients
with Parkinson's disease.
Appl Neuropsychol. 1999;6(3):129-46.
PMID: 10497689; UI: 99427339.
Kienzl E, et al.
Iron as catalyst for oxidative stress in the pathogenesis of
Parkinson's disease?
Life Sci. 1999;65(18-19):1973-6.
PMID: 10576448; UI: 20041867.
Beuter A, et al.
Using frequency domain characteristics to discriminate physiologic and
parkinsonian tremors.
J Clin Neurophysiol. 1999 Sep;16(5):484-94.
PMID: 10576231; UI: 20041650.
Pennathur S, et al.
Mass Spectrometric Quantification of 3-Nitrotyrosine, ortho-Tyrosine,
and o,o'-Dityrosine in Brain Tissue of MPTP treated Mice, a Model of
Oxidative Stress in Parkinson's Disease.
J Biol Chem. 1999 Dec 3;274(49):34621-34628.
PMID: 10574926.
Cutillas B, et al.
Caspase inhibition protects nigral neurons against 6-OHDA-induced
retrograde degeneration.
Neuroreport. 1999 Aug 20;10(12):2605-8.
PMID: 10574377; UI: 20039534.
Pierantozzi M, et al.
The effect of deep brain stimulation on the frontal N30 component of
somatosensory evoked potentials in advanced Parkinson's disease
patients.
Clin Neurophysiol. 1999 Oct;110(10):1700-7.
PMID: 10574285; UI: 20039442.
Sabate M, et al.
Vitiligo associated with tolcapone and levodopa in a patient with
Parkinson's disease.
Ann Pharmacother. 1999 Nov;33(11):1228-9. No abstract available.
PMID: 10573327; UI: 20037998.
Frank W, et al.
Low dose cabergoline induced interstitial pneumonitis.
Eur Respir J. 1999 Oct;14(4):968-70.
PMID: 10573251; UI: 20037922.
Rudolf J, et al.
Deterioration of parkinsonian symptoms following treatment of
dopaminergic hallucinosis with olanzapine.
Eur Psychiatry. 1999 Oct;14(6):356-7.
PMID: 10572371; UI: 20048779.
Berger HJ, et al.
Relationship between Memory Strategies and Motor Symptoms in
Parkinson's Disease.
J Clin Exp Neuropsychol. 1999 Oct;21(5):677-684.
PMID: 10572286.
Martinez-Martin P, et al.
Conversion to controlled-release levodopa/carbidopa treatment and
quality of life as measured by the Nottingham Health Profile. The Star
Study Group.
Neurologia. 1999 Aug-Sep;14(7):338-43.
PMID: 10570620; UI: 20037198.
Tsui JK, et al.
Occupational risk factors in Parkinson's disease.
Can J Public Health. 1999 Sep-Oct;90(5):334-7.
PMID: 10570579; UI: 20037157.
Piccini P, et al.
Dopamine release from nigral transplants visualized in vivo in a
Parkinson's patient.
Nat Neurosci. 1999 Dec;2(12):1137-1140.
PMID: 10570493.
Barker RA, et al.
Functional integration of neural grafts in Parkinson's disease.
Nat Neurosci. 1999 Dec;2(12):1047-1048.
PMID: 10570477.
de Bie RM, et al.
Unilateral pallidotomy in Parkinson's disease: a randomised,
single-blind, multicentre trial.
Lancet. 1999 Nov 13;354(9191):1665-9.
PMID: 10568567; UI: 20033215.
Quinn N.
Progress in functional neurosurgery for Parkinson's disease.
Lancet. 1999 Nov 13;354(9191):1658-9. No abstract available.
PMID: 10568561; UI: 20033209.
Ilic TV, et al.
Oxidative stress indicators are elevated in de novo Parkinson's
disease patients.
Funct Neurol. 1999 Jul-Sep;14(3):141-7.
PMID: 10568214; UI: 20034209.
Lin J, et al.
Absence of G209A and G88C Mutations in the Alpha-Synuclein Gene of
Parkinson's Disease in a Chinese Population.
Eur Neurol. 1999 Nov;42(4):217-220.
PMID: 10567818.
Hutchinson M, et al.
Parkinson's disease: a novel MRI method for determining structural
changes in the substantia nigra.
J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):815-818.
PMID: 10567508.
Sakatani K, et al.
Changes in cerebral blood oxygenation of the frontal lobe induced by
direct electrical stimulation of thalamus and globus pallidus: a near
infrared spectroscopy study.
J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):769-773.
PMID: 10567495.
Rinne JO, et al.
Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in
assessing disability in Parkinson's disease.
J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):737-741.
PMID: 10567489.
Micek ST, et al.
Tolcapone: a novel approach to Parkinson's disease.
Am J Health Syst Pharm. 1999 Nov 1;56(21):2195-205.
PMID: 10565698; UI: 20029428.
Dunnett SB.
Repair of the damaged brain. The alfred meyer memorial lecture 1998.
Neuropathol Appl Neurobiol. 1999 Oct;25(5):351-62.
PMID: 10564524; UI: 20032058.
Meredith GE, et al.
Immunocytochemical characterization of catecholaminergic neurons in
the rat striatum following dopamine-depleting lesions.
Eur J Neurosci. 1999 Oct;11(10):3585-96.
PMID: 10564366; UI: 20032211.
Jaber M, et al.
Differential regulation of tyrosine hydroxylase in the basal ganglia
of mice lacking the dopamine transporter.
Eur J Neurosci. 1999 Oct;11(10):3499-511.
PMID: 10564358; UI: 20032203.
Maraganore DM, et al.
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene
in Parkinson's disease.
Neurology. 1999 Nov 10;53(8):1858-60.
PMID: 10563640; UI: 20025164.
[No authors listed]
Developments in the treatment of Parkinson's disease.
Drug Ther Bull. 1999 May;37(5):36-40.
PMID: 10563057; UI: 20028797.
Phillips NJ, et al.
Validity of mortality data for Parkinson's disease.
J Epidemiol Community Health. 1999 Sep;53(9):587-8. No abstract
available.
PMID: 10562888; UI: 20028628.
Iansek R.
Key points in the management of Parkinson's disease.
Aust Fam Physician. 1999 Sep;28(9):897-901.
PMID: 10561888; UI: 20024531.
Ihara Y, et al.
Hydroxyl radical and superoxide dismutase in blood of patients with
Parkinson's disease: relationship to clinical data.
J Neurol Sci. 1999 Nov 30;170(2):90-95.
PMID: 10561523.
Bennett JP.
Free radicals, oxidative stress and the origin of Parkinson's disease.
J Neurol Sci. 1999 Nov 30;170(2):75-76. No abstract available.
PMID: 10561521.
Galvin JE, et al.
Axon pathology in Parkinson's disease and lewy body dementia
hippocampus contains alpha-, beta-, and gamma-synuclein.
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13450-5.
PMID: 10557341; UI: 20027568.
Scheife RT.
Successful orchestration of antiparkinsonian pharmacotherapy.
Pharmacotherapy. 1999 Nov;19(11 Pt 2):180S-186S.
PMID: 10555946; UI: 20022872.
Luer MS.
Interventions to achieve tonic exposure to levodopa: delaying or
preventing the onset of motor complications.
Pharmacotherapy. 1999 Nov;19(11 Pt 2):169S-179S.
PMID: 10555945; UI: 20022871.
Gottwald MD.
Maximizing the benefit: risk ratio of levodopa therapy in Parkinson's
disease.
Pharmacotherapy. 1999 Nov;19(11 Pt 2):162S-168S.
PMID: 10555944; UI: 20022870.
Lapane KL, et al.
Prevalence, clinical characteristics, and pharmacologic treatment of
Parkinson's disease in residents in long-term care facilities. SAGE
Study Group.
Pharmacotherapy. 1999 Nov;19(11):1321-7.
PMID: 10555938; UI: 20022864.
Schulz JB, et al.
Molecular pathogenesis of movement disorders: are protein aggregates a
common link in neuronal degeneration?
Curr Opin Neurol. 1999 Aug;12(4):433-9.
PMID: 10555832; UI: 20022758.
Spacey SD, et al.
The genetics of Parkinson's disease.
Curr Opin Neurol. 1999 Aug;12(4):427-32.
PMID: 10555831; UI: 20022757.
Krack P, et al.
Surgical treatment of Parkinson's disease.
Curr Opin Neurol. 1999 Aug;12(4):417-25.
PMID: 10555830; UI: 20022756.
Poewe W.
Recent advances in the drug treatment of Parkinson's disease.
Curr Opin Neurol. 1999 Aug;12(4):411-5. No abstract available.
PMID: 10555829; UI: 20022755.
Metman LV, et al.
Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study.
Arch Neurol. 1999 Nov;56(11):1383-6.
PMID: 10555659; UI: 20022585.
Melnick ME, et al.
Effect of pallidotomy on postural control and motor function in
Parkinson disease.
Arch Neurol. 1999 Nov;56(11):1361-5.
PMID: 10555656; UI: 20022582.
Murer MG, et al.
Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?
Drug Saf. 1999 Nov;21(5):339-52.
PMID: 10554050; UI: 20019478.
Papa SM, et al.
Internal globus pallidus discharge is nearly suppressed during
levodopa-induced dyskinesias.
Ann Neurol. 1999 Nov;46(5):732-8.
PMID: 10553990; UI: 20019418.
Ouchi Y, et al.
Presynaptic and postsynaptic dopaminergic binding densities in the
nigrostriatal and mesocortical systems in early Parkinson's disease: a
double-tracer positron emission tomography study.
Ann Neurol. 1999 Nov;46(5):723-31.
PMID: 10553989; UI: 20019417.
------------------------------------------------------------------------
janet paterson
52 now / 41 dx / 37 onset
http://www.geocities.com/SoHo/Village/6263/
613 256 8340 po box 171 almonte ontario canada k0a 1a0
